Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody

Effective Phagocytosis of Low Her2 Tumor Cell Lines with Engineered, Aglycosylated IgG Displaying High FcγRIIa Affinity and Selectivity

(2012) Sang Taek Jung et al.   ACS Chemical Biology

Awaiting a New Era of Cancer Immunotherapy

(2012) C. W. Hong et al.   CANCER RESEARCH

Antibody-Based Immunotherapy of Cancer

(2012) Louis M. Weiner et al.   CELL

Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials

(2012) A. Van Driessche et al.   ONCOLOGIST

An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells

(2011) A. Sergeeva et al.   BLOOD

MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing

(2011) Lei Bao et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Targeting Intracellular Oncoproteins with Antibody Therapy or Vaccination

(2011) K. Guo et al.   Science Translational Medicine

Hidden Immunotherapy Targets Challenge Dogma

(2011) S. Ferrone   Science Translational Medicine

Medical Treatment of Mesothelioma: Anything New?

(2011) Nagio Takigawa et al.   Current Oncology Reports

Malignant Pleural Mesothelioma

(2011) Siva Raja et al.   Current Oncology Reports

Characterization of chronic myeloid leukemia stem cells

(2010) Jonathan M. Gerber et al.   AMERICAN JOURNAL OF HEMATOLOGY

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia

(2010) P. G. Maslak et al.   BLOOD

WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer

(2010) Lee M. Krug et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia

(2010) Mark P. Chao et al.   CANCER RESEARCH

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

(2010) Mark P. Chao et al.   CELL

Sequential Cytarabine and  -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia

(2010) T. L. Rosenblat et al.   CLINICAL CANCER RESEARCH

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

(2010) J. Greiner et al.   HAEMATOLOGICA

TCR Mimic Monoclonal Antibody Targets a Specific Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth In Vivo Using Breast Cancer Models

(2010) Bhavna Verma et al.   JOURNAL OF IMMUNOLOGY

Production of Human Monoclonal Antibodies against FcεRIα by a Method Combiningin VitroImmunization with Phage Display

(2009) Kosuke TOMIMATSU et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

(2009) U. Keilholz et al.   BLOOD

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Identification of a Human Cyclin D1-Derived Peptide that Induces Human Cytotoxic CD4 T Cells

(2009) Tao Dao et al.   PLoS One

Antitumor Activity of Immunotoxins with T-Cell Receptor-like Specificity against Human Melanoma Xenografts

(2008) E. Klechevsky et al.   CANCER RESEARCH